Animal models and biomarkers of neuropathy in diabetic rodents

Indian Journal of Pharmacology

Volumn 42, Issue 3, 2010, Pages 129-134

  Shaikh, A S ^a   Somani, R S ^a  

^a SINHGAD COLLEGE OF PHARMACY   (India)

Author keywords

Biomarker; diabetic neuropathy; diabetic rodents

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALLOXAN; ALPHA TUBULIN; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; GALACTOSE; GENE PRODUCT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NERVE GROWTH FACTOR; NEUROMODULIN; NEUROPEPTIDE Y; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STREPTOZOCIN; SUBSTANCE P; SUPEROXIDE DISMUTASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLODYNIA; ANIMAL MODEL; AUTONOMIC NEUROPATHY; BIOBREEDING RAT; BLOOD FLOW; CHINESE HAMSTER; DEMYELINATION; DIABETIC NEUROPATHY; DIET; DOWN REGULATION; DRUG INDUCED DISEASE; DRUG MECHANISM; FOREFOOT; GASTROINTESTINAL TRANSIT; GOTO KAKIZAKI RAT; HUMAN; HYPERALGESIA; HYPOALGESIA; IMMUNOREACTIVITY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MOTOR COORDINATION; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; NERVE DEGENERATION; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONOBESE DIABETIC MOUSE; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; QUALITY OF LIFE; REVIEW; SCIATIC NERVE; SENSORIMOTOR FUNCTION; SKIN NERVE; STOMACH EMPTYING; ZUCKER DIABETIC FATTY RAT;

EID: 77955433933     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.66833     Document Type: Review

References (44)

1. Said G. Diabetic neuropathy. Nat Clin Pract Neurol 2007;3:331-340
2. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care 2005;28:956-962
3. Stuart CA. Diabetic neuropathy models: Are they relevant? Drug Disco Today Dis Models 2006;3:397-402.
4. Cameron NE, Cotter MA, Jack AM, Basso MD, Hohman TC. Protein kinase C effect on nerve function, perfusion, Na(+), K(+)-ATPase activity and glutathione content in diabetic rat. Diabetologia 1999;42:1120-1130
5. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK. Anti-oxidant and pro-oxidant effect on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 1994;37:449-459
6. Li F, Szabo C, Pacher P, Southan GJ, Abatan OI, Charniauskaya T, et al. Evaluationof orally active poly (ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 2004;47:710-717
7. Morani AS, Bodhankar SL. Neuroprotective effect of early treatment with pioglitazone and pyridoxine hydrochloride in alloxan induced diabetes in rats. Pharmacol online 2007;2:418-428
8. Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004;47:718-724
9. Karra A, Muller I, Janelle M, Ryals I, Eva LF, Douglas EW. Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. Diabetes 2008;57:1693-1701
10. Pittenger G, Mehrabyan A, Simmons K, Amandarice, Dublin C, Barlow P, et al. Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord 2005;3:113-121
11. Sharma AK, Thomas PK, Baker RW. Peripheral nerve abnormalities related to galectose administration in rats. J Neurol Neurosurg Psychiatry 1976;39:794-802.
12. Michael WK, Kevin CD, Marketta B, Andrew PM. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galectose and streptozotocin diabetes. Brain Res 1998;810:130-137
13. Irina GO, Olga I, Valeriy VL, Ivan AP, Nazar M, Jerry LN, et al. High-fat-diet-induced neurpathy of pre-diabetes and obesity-effect of "healthy" diet and aldose reductase inhibition. Diabetes 2007;56:2598-2608
14. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 2008;120:1-34.
15. Jason D, Freshwater BS, Nigel A, Calcutt P. Low doses of formalin reveal allodynia in diabetic rats. J Neurop Pain Symp Palliat 2005;1:39-46.
16. Dyck PJ, Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Nerve growth factor study group. Diabetes Care 2000;23:510-517
17. Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol 2002;50:205-228
18. Courteix C, Eschalier A, Lavarenne J. Streptozotocin-induced diabetic rats: Behavioural evidence for a model of chronic pain. Pain 1993;53:81-88
19. Fox A, Eastwood C, Gentry C, Manning D, Urban L. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 1999;81:307-316
20. Piercy V, Banner SE, Bhattacharyya A. Thermal, but not mechanical, nociceptive behavior is altered in the Zucker diabetic fatty rat and is independent of glycemic status. J Diabetes Complications 1999;13:163-169
21. Calcutt NA, Dines KC, Cesena RM. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism 1998;47:650-656
22. Cavanagh PR, Derr JA, Ulbrecht JS, Maser RE, Orchard TJ. Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus. Diabet Med 1992;9:469-474
23. Sherbel U, Raghupathi R, Nakamura M, Saatman KE, Trojanowski JQ, Neugebaumer E, et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A 1999;96:8721-8726
24. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001;50:1927-1937
25. Nickander KK, McPhee BR, Low PA, Tritschler H. Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 1996;21:631-639
26. Pop-Busui R, Marinescu V, Van HC, Li F, Sullivan K, Greene DA, et al. Dissection of metabolic, vascular and nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-L-carnitine administration. Diabetes 2002;51:2619-2628
27. Vareniuk I, Pavlov IA, Drel VR, Lyzogubov VV, Ilnytska O, Bell SR. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol 2007;205:425-436
28. Garcia SF, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, et al. Diabetic endothelial dysfunction: The role of poly (ADP-ribose) polymerase activation. Nat Med 2001;7:108-113
29. Low PA, Tuck R. Effects of changes of blood pressure, respiratory acidosis and blood flow in the sciatic nerve of the rat. J Physiol 1984;347:513-524
30. Gurrant GO, Moss CW. Determinations of monosaccharide as aldononitrite, o-methyleoxime, alditol, and cyclitol acetate derivatives by gas chromatography. Anal Chem 1984;56:633-638
31. Takeuchi M, Low PA. Dynamic peripheral nerve metabolic and vascular responses to exsanguination. Am J Physiol 1987;253:E349-53.
32. Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE. Natural history of diabetic gastroparesis. Diabetes Care 1999;22:503-507
33. Bijender S, Harish D, Rishi S, Patil BM. Effect of vitamine E on the impaired gastrointestinal activity of streptozotocin induced diabetic rats. Indian J Pharmacol 2003;35:186-187
34. Wen-Cai Q, Zhi-Gang W, Ran L, Wei-Gang W, Xiao-Dong H, Jun Y, et al. Ghrelin improves delayed gastrointestinal transit in alloxan-induced diabetic mice. World J Gastroenterol 2008;14:2572-2577
35. Karanth SS, Springall DR, Francavilla S, Mirrlees DJ, Polak JM. Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats. Histochemistry 1990;94:659-666
36. Christianson JA, Riekhof JT, Wright DE. Restorative effects of neurotrophin treatment on diabetes induced cutaneous axon loss in mice. Exp Neurol 2003;179:188-199
37. Chen YS, Chung SS, Chung SK. Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice. Diabetes 2005;54:3112-3118
38. Beiswenger K, Calcutt NA, Mizisin AP. The time course of structural and functional changes in epidermal nerves of a mouse model of type 1 diabetes. J Peripher Nerv Syst 2007;12:8-9.
39. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA. Diminished neuropeptide levels contribute to impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002;108:122-128
40. James MK, Douglas WZ. Experimental diabetic neuropathy with spontaneous recovery is there irreparable damage? Diabetes 2005;54:830-837
41. Yasuda H, Terada M, Maeda K, Kogawa S, Sanada M, Haneda M, et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003;69:229-285
42. Delcroix JD, Tomlinson DR, Fernyhough P. Diabetes and axotomy-induced deficits in retrograde axonal transport of nerve growth factor correlate with decreased levels of p75LNTR protein in lumbar dorsal root ganglia. Brain Res Mol Brain Res 1997;51:82-90.
43. Chilton L, Middlemas A, Gardiner N, Tomlinson DR. The p75 neurotrophin receptor appears in plasma in diabetic rats: Characterisation of a potential early test for neuropathy. Diabetologia 2004;47:1924-1930
44. Safinaz SI. Protective effect of hesperidin, a citrus bioflavonoid, on diabetes-induced brain damage in rats. J Appl Sci Res 2008;4:84-95.